Circulating Tumor Cells (CTC) Market, Size, Share, Opportunities and Forecast, 2020-2027

SKU: DPC238 | Last Updated On: Sep 22 2020 | No. of Pages: 178 | Available Formats

> Global Circulating Tumor Cells (CTC) Market Expected to reach a high CAGR of 15.20% By 2027: DataM Intelligence

Global Circulating Tumor Cells (CTC) Market is segmented By Technology (CTC Detection Technology, CTC Enrichment Technology), By Application (EMT Biomarkers Development, Tumorigenesis Research, Cancer Stem Cell, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share Outlook, and Opportunity Analysis, 2020-2027

 

Circulating Tumor Cells (CTC) Market

Market Overview

The Global Circulating Tumor Cells (CTCs) Market is expected to grow at a CAGR of 15.20% during the forecast period (2020-2027) 

Circulating tumor cells (CTCs) are cells that have shed into the vasculature or lymphatics from a primary tumor and are carried around the body in the blood circulation. CTC’s constitute seeds for the subsequent growth of additional tumors in distant organs, a mechanism that is responsible for the vast majority of cancer-related deaths. The detection and analysis of CTCs can assist early patient prognoses and determine appropriate tailored treatments. Growing incidences of cancer is expected to propel the global circulating tumor cells market over the forecast period (2019-2026).

Market Dynamics 

Growing incidences and prevalence of cancer globally is one of the major factors driving the global circulating tumor cells market. According to the WHO (World Health Organization), in 2018, there were an estimated of 17 million new cases globally, about 1 in 6 deaths is due to cancer. Additionally, the introduction of novel technologies for enumeration of CTC coupled with initiatives taken by the governments and increasing R&D activities is anticipated to fuel the market growth. In 2019, TATAA Bio center launched the qPCR assays for the profiling of circulating tumor cells.

However, factors like the high cost of diagnosis and lack of commercialized products are hampering the market growth.

Market Segment Analysis 

Based on the application of the global Circulating Tumor Cells (CTC) market is broadly segmented as cancer stem cell research, Tumorigenesis Research, EMT Biomarkers Development, and others. Among all these cancer stem cell research segment accounted for major market share in 2018 and is projected to grow at a high pace over the forecast period (2019-2026) in the global circulating tumor cells (CTC) market. It involves study of several cancer types, such as breast, prostate, lung, nervous, thyroid, and leukemia. It is owing to the active participation of prominent entities, such as University of Michigan Comprehensive Cancer Centre and Institute of Stem Cell Biology and Regenerative Medicine in R&D activities. 

Geographical Analysis 

The global Circulating Tumor Cells (CTC) market is segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. North America region accounted for major market share in 2018 in the global circulating tumor cells market, owing to rising incidences of cancer, growing oncology research funding, and favorable government initiatives for clinical diagnostic products. According to the American Cancer Society, in 2018, above 15.5% of Americans had a history of cancer by 2016. However, during the forecast period (2019-2026), the Asia Pacific region is expected to grow at a significant rate in the global market. It is due to infrastructural development in care centers and increased sales of CTC diagnostic tests. Additionally, rising need for new diagnostic methods for cancer has encouraged R&D in developing economies of APAC.

Competitive Analysis 

Significant players of the global circulating tumor cells market are Clearbridge BioMedics, Qiagen NV, Advanced Cell Diagnostics, Inc, Menarini Silicon Biosystems, Aviva Biosciences, Biocept Inc, Creatv Micro Tech, Inc., LungLife AI, Inc., Miltenyi Biotec, and others. Majority of these prominent players are adopting few organic and inorganic strategies such as product launches, collaboration, and product agreements, and other key developments to enhance their product portfolio in the global circulating tumor cells market. For instance, 

• In March 2018, Biocept Inc received a patent for its Target Selector assays for molecular analysis to improve the patient diagnosis with cancer in China. 

• In October 2018, Precision acquired Houston-based ApoCell.

• In November 2017, - Clearbridge BioMedics and Leica Biosystems partnered, and co-marketing each other's products to support circulating tumor cell (CTC) research.

• In April 2017, Menarini-Silicon Biosystems, Inc. agreed to purchase CELLSEARCH® Circulating Tumor Cell System from Janssen Diagnostics, LLC.

• In February 2016, Fluxion Biosciences, Inc. launched two new kits for enhanced CTC isolation and recovery that are designed to work exclusively with the IsoFlux Liquid Biopsy system.

Why Purchase the Report?

• Visualize the composition of the Circulating Tumor Cells (CTC) market across each indication, in terms of technology and application options, highlighting the key commercial assets and players.

• Identify commercial opportunities in the Circulating Tumor Cells (CTC) market by analyzing trends and co-development deals. 

• Excel data sheet with thousands of data points of the Circulating Tumor Cells (CTC) market - level 4/5 segmentation.

• A PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

• Product mapping in excel for the key products of all major market players

Target Audience:

• Equipment Suppliers/ Buyers

• Service Providers/ Buyers

• Industry Investors/Investment Bankers

Education & Research Institutes

• Research Professionals

• Emerging Companies

• Manufacturers

 

Related Reports

Neuroendocrine Tumor Treatment

Tumor Ablation Market

 

 

Table of Contents

1. Global Circulating Tumor Cells (CTC) Market Methodology and Scope

1.1. Research Methodology

1.2. Research Objective and Scope of the Report

2. Global Circulating Tumor Cells (CTC) Market – Market Definition and Overview

3. Global Circulating Tumor Cells (CTC) Market – Executive Summary

3.1. Market Snippet by Technology

3.2. Market Snippet by Application

3.3. Market Snippet by Region

4. Global Circulating Tumor Cells (CTC) Market – Market Dynamics

4.1. Market Impacting Factors

4.1.1. Drivers

4.1.1.1. incidences and prevalence of cancer 

4.1.1.2. Technology Advancements

4.1.2. Restraints

4.1.2.1. Cost of Diagnosis

4.1.3. Opportunity

4.1.4. Impact Analysis

5. Global Circulating Tumor Cells (CTC) Market – Industry Analysis 

5.1. Porter's Five Forces Analysis 

6. Global Circulating Tumor Cells (CTC) Market – By Technology

6.1.1. Introduction 

6.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology

6.1.3. Market Attractiveness Index, By Technology

6.2. CTC Detection Technology

6.2.1. Introduction

6.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2026

6.2.2.1. Immunocytochemical Technology

6.2.2.2. Molecular-based technology

6.2.2.3. Xenotransplantation Technology

6.2.2.4. Others

6.3. CTC Enrichment Technology

6.3.1. Single Spiral Micro Channel

6.3.2. Microchips

6.3.3. Negative Selection

6.3.4. In-Vivo Positive Selection

6.3.5. Ex-Vivo Positive Selection

6.3.6. Others

7. Global Circulating Tumor Cells (CTC) Market – By Application

7.1.1. Introduction 

7.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

7.1.3. Market Attractiveness Index, By Application

7.2. EMT Biomakers Development

7.2.1. Introduction

7.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2026

7.3. Tumorigenesis Research

7.4. Cancer Stem Cell

7.5. Others

8. Global Circulating Tumor Cells (CTC) Market – By Region

8.1. Introduction 

8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region

8.1.2. Market Attractiveness Index, By Region

8.2. North America

8.2.1. Introduction

8.2.2. Key Region-Specific Dynamics

8.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

8.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology

8.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

8.2.5.1. The U.S.

8.2.5.2. Canada

8.2.5.3. Mexico

8.3. Europe

8.3.1. Introduction

8.3.2. Key Region-Specific Dynamics

8.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

8.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology

8.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

8.3.5.1. Germany

8.3.5.2. The U.K.

8.3.5.3. France

8.3.5.4. Italy

8.3.5.5. Spain

8.3.5.6. Rest of Europe

8.4. South America

8.4.1. Introduction

8.4.2. Key Region-Specific Dynamics

8.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

8.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology

8.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

8.4.5.1. Brazil

8.4.5.2. Argentina

8.4.5.3. Rest of South America

8.5. Asia Pacific

8.5.1. Introduction

8.5.2. Key Region-Specific Dynamics

8.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

8.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology

8.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

8.5.5.1. China

8.5.5.2. India

8.5.5.3. Japan

8.5.5.4. Australia

8.5.5.5. Rest of Asia Pacific

8.6. Middle East & Africa

8.6.1. Introduction

8.6.2. Key Region-Specific Dynamics

8.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

8.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology

9. Global Circulating Tumor Cells (CTC) Market – Competitive Landscape

9.1. Competitive Scenario

9.2. Competitor Circulating Tumor Cells (CTC) Strategy Analysis

9.3. Comparative Technology Portfolio Analysis

9.4. Market Positioning/Share Analysis

9.5. Mergers and Acquisitions Analysis

10. Global Circulating Tumor Cells (CTC) Market - Company Profiles

10.1. Advanced Cell Diagnostics, Inc

10.1.1. Company Overview

10.1.2. Technology Portfolio and Description

10.1.3. Key Highlights

10.1.4. Financial Overview

10.2. Aviva Biosciences

10.3. Biocept Inc

10.4. Creatv Micro Tech, Inc.

10.5. LungLife AI, Inc.

10.6. Menarini Silicon Biosystems

10.7. Miltenyi Biotec

10.8. Qiagen NV

10.9. Clearbridge BioMedics

10.10. Company

11. Global Circulating Tumor Cells (CTC) Market – Premium Insights

12. Global Circulating Tumor Cells (CTC) Market – DataM 

12.1. Appendix

12.2. About Us and Technology

12.3. Contact Us

List of Tables & Figures

List of Tables

TABLE 01. GLOBAL CIRCULATING TUMOR CELLS (CTC) MARKET VALUE, 2018, 2022 & 2027, BY TECHNOLOGY, ($MILLION)

TABLE 02. GLOBAL CIRCULATING TUMOR CELLS (CTC) MARKET VALUE 2018, 2022 & 2027, BY APPLICATION, ($MILLION)

TABLE 03. GLOBAL CIRCULATING TUMOR CELLS (CTC) MARKET VALUE 2018, 2022 & 2027, BY REGION, ($MILLION)

TABLE 04. GLOBAL CIRCULATING TUMOR CELLS (CTC) MARKET SHARE 2018, 2022 & 2027 (%), BY TECHNOLOGY ($MILLION)

TABLE 05. GLOBAL CIRCULATING TUMOR CELLS (CTC) MARKET VALUE, BY TECHNOLOGY, 2018–2027 ($MILLION)

TABLE 06. GLOBAL CIRCULATING TUMOR CELLS (CTC) MARKET SHARE 2018, 2022 & 2027 (%), BY APPLICATION ($MILLION)

TABLE 07. GLOBAL CIRCULATING TUMOR CELLS (CTC) MARKET VALUE, BY APPLICATION, 2018–2027 ($MILLION)

TABLE 08. GLOBAL CIRCULATING TUMOR CELLS (CTC) MARKET SHARE 2018, 2022 & 2027 (%), BY REGION ($MILLION)

TABLE 09. GLOBAL CIRCULATING TUMOR CELLS (CTC) MARKET VALUE, BY REGION, 2018–2027 ($MILLION)

TABLE 10. NORTH AMERICA CIRCULATING TUMOR CELLS (CTC) MARKET VALUE, BY TECHNOLOGY, 2018–2027 ($MILLION)

TABLE 11. NORTH AMERICA CIRCULATING TUMOR CELLS (CTC) MARKET VALUE, BY APPLICATION, 2018–2027 ($MILLION)

TABLE 12. NORTH AMERICA CIRCULATING TUMOR CELLS (CTC) MARKET VALUE, BY COUNTRY, 2018–2027 ($MILLION)

TABLE 13. SOUTH AMERICA CIRCULATING TUMOR CELLS (CTC) MARKET VALUE, BY TECHNOLOGY, 2018–2027 ($MILLION)

TABLE 14. SOUTH AMERICA CIRCULATING TUMOR CELLS (CTC) MARKET VALUE, BY APPLICATION, 2018–2027 ($MILLION)

TABLE 15. SOUTH AMERICA CIRCULATING TUMOR CELLS (CTC) MARKET VALUE, BY COUNTRY, 2018–2027 ($MILLION)

TABLE 16. EUROPE CIRCULATING TUMOR CELLS (CTC) MARKET VALUE, BY TECHNOLOGY, 2018–2027 ($MILLION)

TABLE 17. EUROPE CIRCULATING TUMOR CELLS (CTC) MARKET VALUE, BY APPLICATION, 2018–2027 ($MILLION)

TABLE 18. EUROPE CIRCULATING TUMOR CELLS (CTC) MARKET VALUE, BY COUNTRY, 2018–2027 ($MILLION)

TABLE 19. ASIA PACIFIC CIRCULATING TUMOR CELLS (CTC) MARKET VALUE, BY TECHNOLOGY, 2018–2027 ($MILLION)

TABLE 20. ASIA PACIFIC CIRCULATING TUMOR CELLS (CTC) MARKET VALUE, BY APPLICATION, 2018–2027 ($MILLION)

TABLE 21. ASIA PACIFIC CIRCULATING TUMOR CELLS (CTC) MARKET VALUE, BY COUNTRY, 2018–2027 ($MILLION)

TABLE 22. MIDDLE EAST & AFRICA CIRCULATING TUMOR CELLS (CTC) MARKET VALUE, BY TECHNOLOGY, 2018–2027 ($MILLION)

TABLE 23. MIDDLE EAST & AFRICA CIRCULATING TUMOR CELLS (CTC) MARKET VALUE, BY APPLICATION, 2018–2027 ($MILLION)

TABLE 24. ADVANCED CELL DIAGNOSTICS, INC.: OVERVIEW

TABLE 25. ADVANCED CELL DIAGNOSTICS, INC.: TECHNOLOGY PORTFOLIO

TABLE 26. ADVANCED CELL DIAGNOSTICS, INC.: KEY DEVELOPMENTS

TABLE 27. AVIVA BIOSCIENCES: OVERVIEW

TABLE 28. AVIVA BIOSCIENCES: TECHNOLOGY PORTFOLIO

TABLE 29. AVIVA BIOSCIENCES: KEY DEVELOPMENTS

TABLE 30. BIOCEPT INC: OVERVIEW

TABLE 31. BIOCEPT INC: TECHNOLOGY PORTFOLIO

TABLE 32. BIOCEPT INC: KEY DEVELOPMENTS

TABLE 33. CREATV MICRO TECH, INC: OVERVIEW

TABLE 34. CREATV MICRO TECH, INC: TECHNOLOGY PORTFOLIO

TABLE 35. CREATV MICRO TECH, INC: KEY DEVELOPMENTS

TABLE 36. LUNGLIFE AI, INC.: OVERVIEW

TABLE 37. LUNGLIFE AI, INC.: TECHNOLOGY PORTFOLIO

TABLE 38. LUNGLIFE AI, INC.: KEY DEVELOPMENTS

TABLE 39. MENARINI SILICON BIOSYSTEMS, INC: OVERVIEW

TABLE 40. MENARINI SILICON BIOSYSTEMS, INC: TECHNOLOGY PORTFOLIO

TABLE 41. MENARINI SILICON BIOSYSTEMS, INC: KEY DEVELOPMENTS

TABLE 42. MILTENYI BIOTEC.: OVERVIEW

TABLE 43. MILTENYI BIOTEC.: TECHNOLOGY PORTFOLIO

TABLE 44. MILTENYI BIOTEC.: KG: KEY DEVELOPMENTS

TABLE 45. QIAGEN NV.: OVERVIEW

TABLE 46. QIAGEN NV.: TECHNOLOGY PORTFOLIO

TABLE 47. QIAGEN NV.: KEY DEVELOPMENTS

TABLE 48. CLEARBRIDGE BIOMEDICS: OVERVIEW

TABLE 49. CLEARBRIDGE BIOMEDICS: TECHNOLOGY PORTFOLIO

TABLE 50. CLEARBRIDGE BIOMEDICS: KEY DEVELOPMENTS

TABLE 51. COMPANY 10: OVERVIEW

TABLE 52. COMPANY 10: TECHNOLOGY PORTFOLIO

TABLE 53. COMPANY 10: KEY DEVELOPMENTS

 

List of Figures

FIGURE 01. GLOBAL CIRCULATING TUMOR CELLS (CTC) MARKET SHARE, 2018 & 2027 (%), BY TECHNOLOGY

FIGURE 02. GLOBAL CIRCULATING TUMOR CELLS (CTC) MARKET SHARE, 2018 & 2027 (%), BY APPLICATION

FIGURE 03. GLOBAL CIRCULATING TUMOR CELLS (CTC) MARKET SHARE, 2018 & 2027 (%), BY REGION

FIGURE 04. GLOBAL CIRCULATING TUMOR CELLS (CTC) MARKET VALUE, 2018 - 2027 AND YEAR ON YEAR GROWTH

FIGURE 05. GLOBAL CIRCULATING TUMOR CELLS (CTC) MARKET YEAR ON YEAR GROWTH 2018 TO 2027 (%), BY TECHNOLOGY

FIGURE 06 GLOBAL CIRCULATING TUMOR CELLS (CTC) MARKET VALUE, BY CTC DETECTION TECHNOLOGIES, 2018–2027 ($MILLION)

FIGURE 07 GLOBAL CIRCULATING TUMOR CELLS (CTC) MARKET VALUE, BY CTC ENRICHMENT TECHNOLOGIES, 2018–2027 ($MILLION)

FIGURE 08  GLOBAL CIRCULATING TUMOR CELLS (CTC) MARKET YEAR ON YEAR GROWTH 2018 TO 2027 (%), BY APPLICATION

FIGURE 09 GLOBAL CIRCULATING TUMOR CELLS (CTC) MARKET VALUE, BY EMT BIOMAKERS DEVELOPMENT, 2018–2027 ($MILLION)

FIGURE 10 GLOBAL CIRCULATING TUMOR CELLS (CTC) MARKET VALUE, BY TUMORIGENESIS RESEARCH, 2018–2027 ($MILLION)

FIGURE 11 GLOBAL CIRCULATING TUMOR CELLS (CTC) MARKET VALUE, BY CANCER STEM CELL, 2018–2027 ($MILLION)

FIGURE 12 GLOBAL CIRCULATING TUMOR CELLS (CTC) MARKET VALUE, BY OTHERS, 2018–2027 ($MILLION)

FIGURE 13  GLOBAL CIRCULATING TUMOR CELLS (CTC) MARKET YEAR ON YEAR GROWTH 2018 TO 2027 (%), BY REGION

FIGURE 14 NORTH AMERICA CIRCULATING TUMOR CELLS (CTC) MARKET VALUE, 2018–2027 ($MILLION)

FIGURE 15 NORTH AMERICA CIRCULATING TUMOR CELLS (CTC) MARKET SHARE (%), BY TECHNOLOGY, 2018–2027 ($MILLION)

FIGURE 16 NORTH AMERICA CIRCULATING TUMOR CELLS (CTC) MARKET SHARE (%), BY APPLICATION, 2018–2027 ($MILLION)

FIGURE 17 NORTH AMERICA CIRCULATING TUMOR CELLS (CTC) MARKET SHARE (%), BY COUNTRIES, 2018–2027 ($MILLION)

FIGURE 18 SOUTH AMERICA CIRCULATING TUMOR CELLS (CTC) MARKET VALUE, 2018–2027 ($MILLION)

FIGURE 19 SOUTH AMERICA CIRCULATING TUMOR CELLS (CTC) MARKET SHARE (%), BY TECHNOLOGY, 2018–2027 ($MILLION)

FIGURE 20 SOUTH AMERICA CIRCULATING TUMOR CELLS (CTC) MARKET SHARE (%), BY APPLICATION, 2018–2027 ($MILLION)

FIGURE 21 SOUTH AMERICA CIRCULATING TUMOR CELLS (CTC) MARKET SHARE (%), BY COUNTRIES, 2018–2027 ($MILLION)

FIGURE 22 EUROPE CIRCULATING TUMOR CELLS (CTC) MARKET VALUE, 2018–2027 ($MILLION)

FIGURE 23 EUROPE CIRCULATING TUMOR CELLS (CTC) MARKET SHARE (%), BY TECHNOLOGY, 2018–2027 ($MILLION)

FIGURE 24 EUROPE CIRCULATING TUMOR CELLS (CTC) MARKET SHARE (%), BY APPLICATION, 2018–2027 ($MILLION)

FIGURE 25  EUROPE CIRCULATING TUMOR CELLS (CTC) MARKET SHARE (%), BY COUNTRIES, 2018–2027 ($MILLION)

FIGURE 26  ASIA PACIFIC CIRCULATING TUMOR CELLS (CTC) MARKET VALUE, 2018–2027 ($MILLION)

FIGURE 27 ASIA PACIFIC CIRCULATING TUMOR CELLS (CTC) MARKET SHARE (%), BY TECHNOLOGY, 2018–2027 ($MILLION)

FIGURE 28 ASIA PACIFIC CIRCULATING TUMOR CELLS (CTC) MARKET SHARE (%), BY APPLICATION, 2018–2027 ($MILLION)

FIGURE 29 ASIA PACIFIC CIRCULATING TUMOR CELLS (CTC) MARKET SHARE (%), BY COUNTRIES, 2018–2027 ($MILLION)

FIGURE 30 MIDDLE EAST AND AFRICA CIRCULATING TUMOR CELLS (CTC) MARKET VALUE, 2018–2027 ($MILLION)

FIGURE 31 MIDDLE EAST AND AFRICA CIRCULATING TUMOR CELLS (CTC) MARKET SHARE (%), BY TECHNOLOGY, 2018–2027 ($MILLION)

FIGURE 32 MIDDLE EAST AND AFRICA CIRCULATING TUMOR CELLS (CTC) MARKET SHARE (%), BY APPLICATION, 2018–2027 ($MILLION)

FIGURE 33. ADVANCED CELL DIAGNOSTICS, INC.: FINANCIALS

FIGURE 34. AVIVA BIOSCIENCES: FINANCIALS

FIGURE 35. BIOCEPT INC: FINANCIALS

FIGURE 36 CREATV MICRO TECH, INC: FINANCIALS

FIGURE 37. LUNGLIFE AI, INC.: FINANCIALS

FIGURE 38. MENARINI SILICON BIOSYSTEMS, INC: FINANCIALS

FIGURE 39. MILTENYI BIOTEC.: FINANCIALS

FIGURE 40. QIAGEN NV.: FINANCIALS

FIGURE 41. CLEARBRIDGE BIOMEDICS: FINANCIALS

FIGURE 42. COMPANY 10: FINANCIALS

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
We collate your requirements.
Our global research team is put into action.
We deliver, and make sure your endeavour is a success!

Buy This Report



Get your FREE SAMPLE PROPOSAL with a single click!

linkedinpinterest